Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme

PURPOSE: To determine the safety and efficacy of hypofractionated intensity modulated radiation therapy (Hypo-IMRT) using helical tomotherapy (HT) with concurrent low dose temozolomide (TMZ) followed by adjuvant TMZ in patients with glioblastoma multiforme (GBM). METHODS AND MATERIALS: Adult patient...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Jastaniyah, Noha, Murtha, Albert, Pervez, Nadeem, Le, Duc, Roa, Wilson, Patel, Samir, Mackenzie, Marc, Fulton, Dorcas, Field, Colin, Ghosh, Sunita, Fallone, Gino, Abdulkarim, Bassam
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3599873/
https://ncbi.nlm.nih.gov/pubmed/23425509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-8-38
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki